Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Stands To Be Biggest Beneficiary Of J&J's Exit From Insulin Pump Market

Executive Summary

Animas, a division of Johnson & Johnson, will stop making Animas Vibe and OneTouch Ping insulin pumps, close operations, and exit the insulin pump business, the company announced Oct. 5. J&J is offering patients currently using these devices the option to transfer to Medtronic device. Medtronic is already the leading supplier of insulin pumps worldwide.

Advertisement

Related Content

Market Intel: Insulin Pumps Dominate $7bn-Plus Global Infusion Devices Market
J&J Offloads LifeScan To Private Equity Firm For $2.1bn
Cardiovascular Divisions Boost Medtronic's FYQ2 Top-Line As Hurricane Recovery Continues
J&J's Ethicon Calls For Game-Changing Holistic Approach To Obesity Care
Senseonics, TypeZero Join Forces On Artificial Pancreas
Market Intel: Advent Of Artificial Pancreas Tech To Galvanize Fast-Growing Diabetes Market
Q1 EARNINGS: JnJ bullish in spite of device slump

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT121601

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel